(Q35043107)

English

Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge (English)

1 reference

Europe PubMed Central

6 August 2017

0 references

object named as

rabies virus

1 reference

based on heuristic

inferred from title

Matthias J. Schnell

7

object named as

Matthias J Schnell

1 reference

Europe PubMed Central

6 August 2017

author name string

Waleed Mustafa

1

1 reference

Europe PubMed Central

6 August 2017

Fetweh H Al-Saleem

2

1 reference

Europe PubMed Central

6 August 2017

Zidoon Nasser

3

1 reference

Europe PubMed Central

6 August 2017

Rebecca M Olson

4

1 reference

Europe PubMed Central

6 August 2017

Jeffrey A Mattis

5

1 reference

Europe PubMed Central

6 August 2017

Lance L Simpson

6

1 reference

Europe PubMed Central

6 August 2017

language of work or name

0 references

publication date

5 May 2011

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

29

1 reference

Europe PubMed Central

6 August 2017

28

1 reference

Europe PubMed Central

6 August 2017

4638-4645

1 reference

Europe PubMed Central

6 August 2017

Characterization of new formalin-detoxified botulinum neurotoxin toxoids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Subunit vaccine against the seven serotypes of botulism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Rabies virus glycoprotein as a carrier for anthrax protective antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Clostridium botulinum: a bug with beauty and weapon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Identification of the major steps in botulinum toxin action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

On natural and artificial vaccinations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Botulinum and tetanus neurotoxins: structure, function and therapeutic utility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Development of vaccines for prevention of botulism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

A two-phase model of B-cell activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Neurotoxins affecting neuroexocytosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Recombinant rabies virus as potential live-viral vaccines for HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Rabies--risk of exposure and current trends in prevention of human cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Role of repetitive antigen patterns for induction of antibodies against antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Expression of a large, nontoxic fragment of botulinum neurotoxin serotype A and its use as an immunogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Botulism: the present status of the disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Rabies ribonucleocapsid as an oral immunogen and immunological enhancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Clostridium botulinum toxins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

Rabies Vaccine Prepared in Human Cell Cultures: Progress and Perspectives

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

based on heuristic

inferred from DOI database lookup

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

8 July 2018

The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

25 October 2018

An adenoviral vector-based mucosal vaccine is effective in protection against botulism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

25 October 2018

An improved method for development of toxoid vaccines and antitoxins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

25 October 2018

Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

25 October 2018

Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

25 October 2018

Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

25 October 2018

Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114282

25 October 2018

Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

DNA vaccination protects against botulinum neurotoxin type F

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

Purification and amino acid composition of type A botulinum neurotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

Isolation and characterization of the Botulinum neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855-1296) of the toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.045

7 January 2021

Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/21549784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

STUDIES ON IMMUNITY TO TOXINS OF CLOSTRIDIUM BOTULINUM. IX. IMMUNOLOGIC RESPONSE OF MAN TO PURIFIED PENTAVALENT ABCDE BOTULINUM TOXIOD

1 reference

https://pubmed.ncbi.nlm.nih.gov/21549784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2011.04.045

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35043107&oldid=2087486710"